The EarliPoint® System
What is EarliPoint Evaluation?
EarliPoint is an FDA-cleared eye-tracking assessment tool designed for young children (16–30 months) to aid in the diagnosis and evaluation of autism spectrum disorder (ASD).
How it works:
During the assessment, your child watches a series of short, engaging videos of social interactions while the device tracks their eye movements. EarliPoint measures how your child looks at faces, gestures, and social cues, collecting over 100 data points per second. This information is compared to age-based norms to provide objective insights into your child’s social attention and communication development.
Why we include it in our assessment process:
EarliPoint allows for earlier and more accurate understanding of developmental differences. By combining its results with behavioral assessments like the VB-MAPP, we can create more individualized and effective ABA treatment plans. The process is quick, noninvasive, and enjoyable for most children, often taking less than 30 minutes to complete.
What to expect:
Your child will sit comfortably and watch videos on a screen while the device collects data. Afterward, our BCBA reviews the results alongside other assessments and parent input to develop a personalized treatment plan. EarliPoint data does not replace clinical evaluation but adds valuable, objective insight to help us better support your child’s growth and learning.
*The EarliPoint System (EarliTec Diagnostics, Inc.) device is indicated as a tool to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children as early as 16 months, who are at risk based on concerns identified by a parent, caregiver, or healthcare provider. Not for direct consumer purchase; clinician use only.